John Oyler sold $18.1M of BeOne Medicines AG (ONC)

Executed Jul 10, disclosed Jul 15, 4 days later.

Value, as filed

$18.1M

59,594 sh across 11 lots

Executed

Jul 10

the trade date, as filed

Disclosed

Jul 15

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

John Oyler Chief Executive Officer profile →

John Oyler (Chief Executive Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $89.3M of ONC (282,921 sh across 16 lots, as filed), executed Jul 15.

The name

ONC

BeOne Medicines AG ONC · Healthcare · 70 filings in 24 months ticker →

Healthcare · BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States,…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by John Oyler in ONC

ONCSALE BeOne Medicines AG $86.5M
240,739 sh across 22 lots
Exec Aug 10
Filed Aug 12 · 5:53 PM ET ONCSALE BeOne Medicines AG $34.5M
109,433 sh across 13 lots
Exec Jul 20
Filed Jul 22 · 5:03 PM ET ONCSALE BeOne Medicines AG $20.1M
64,577 sh across 8 lots
Exec Jul 17
Filed Jul 17 · 5:36 PM ET ONCSALE BeOne Medicines AG $89.3M
282,921 sh across 16 lots
Exec Jul 15
Filed Jul 17 · 5:31 PM ET ONCSALE BeOne Medicines AG $44.6M
145,861 sh across 6 lots
Exec Jul 14
Filed Jul 14 · 9:26 PM ET ONCSALE BeOne Medicines AG $846K
3,090 sh across 2 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET ONCSALE BeOne Medicines AG $892K
3,360 sh across 2 lots
Exec Jun 16
Filed Jun 18 · 5:30 PM ET ONCSALE BeOne Medicines AG $411K
1,600 sh across 2 lots
Exec Jun 11
Filed Jun 15 · 5:30 PM ET